Strasbourg, France

Cedric Catala

This inventor holds 1 USPTO granted patent. Top assignees: Centre National De La Recherche Scientifique, Université Louis Pasteur. Active years: 2008.


Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2008

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Cedric Catala: Innovator in Hydroxyisoleucine Preparation

Introduction

Cedric Catala is a notable inventor based in Strasbourg, France. He has made significant contributions to the field of chemistry, particularly in the preparation of amino acids. His innovative methods have implications for various applications in pharmaceuticals and biochemistry.

Latest Patents

Cedric Catala holds a patent for a method for preparing 4-hydroxyisoleucine diastereoisomers and enantiomers and derivatives thereof. This invention involves a unique process characterized by reducing an isoxazole derivative under specific conditions to yield the desired derivatives. The method is particularly useful for preparing (2S, 3R, 4S)-4-hydroxyisoleucine, which has potential applications in health and nutrition.

Career Highlights

Throughout his career, Cedric Catala has worked with prestigious institutions such as Université Louis Pasteur and the Centre National de la Recherche Scientifique. His work has been instrumental in advancing research in the field of organic chemistry and amino acid synthesis.

Collaborations

Cedric has collaborated with esteemed colleagues, including Charles Mioskowski and Jean-Michel Becht. These partnerships have fostered a collaborative environment that enhances research and innovation in their respective fields.

Conclusion

Cedric Catala's contributions to the field of chemistry, particularly through his patent on 4-hydroxyisoleucine, highlight his role as an innovator. His work continues to influence the scientific community and pave the way for future advancements in amino acid preparation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…